|
Allergy Therapeutics - Clinical update
2 December 2005 Allergy Therapeutics plc announces rescheduling of Grass Phase III trials Despite having completed its pre-phase III study programme on plan, following consultation with regulatory agencies ...
http://uk.finance.yahoo...
Allergy Therapeutics - Notice of Results
Correction Allergy Therapeutics plc - Notification of Results Released 1 March at 09.30am RNS Number: 0905Z Correction: the time of the analyst presentation should read 10.45am The full amended text appears ...
http://uk.finance.yahoo...
Allergy Therapeutics - Notice of Results-Amendment
Correction Allergy Therapeutics plc - Notification of Results Released 1 March at 09.30am RNS Number: 0905Z Correction: the time of the analyst presentation should read 10.45am The full amended text appears ...
http://uk.finance.yahoo...
Allergy Therapeutics - Approval of Vaccine patent
Allergy Therapeutics plc (or 'the company') Announces approval of fundamental Vaccine technology Patent Allergy Therapeutics plc, the specialist pharmaceutical company focused on allergy vaccination, today ...
http://uk.finance.yahoo...
Allergy Therapeutics - Result of AGM
Result of AGM Allergy Therapeutics plc, the specialty pharmaceuticals company focused on allergy vaccines, is pleased to announce that all the resolutions at the Annual General Meeting of the Company, ...
http://uk.finance.yahoo...
United Allergy Services Announces Company Rebrand
United Allergy Services ™, formerly known as United Allergy Labs™, today announced the company’s new name to better reflect its service role in the delivery of allergy testing and immunotherapy.
http://finance.yahoo.co...
Advent of Spring: allergy patients asked to be cautious
ISLAMABAD: Allergy patients of twin cities of Islamabad and Rawalpindi have been advised to remain cautious with the advent of spring season and pursue all remedial measures to avoid any complication.
http://www.dawn.com/201...
|